• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Synopsys Posts Financial Results for Second Quarter Fiscal Year 2024

    5/22/24 4:05:00 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology
    Get the next $SNPS alert in real time by email

    Results Summary1 

    • Quarterly revenue of $1.455 billion, up approximately 15% year over year and at the high-end of guidance.
    • Quarterly GAAP earnings per diluted share of $1.92; non-GAAP earnings per diluted share of $3.00, up approximately 26% year over year1 and exceeding guidance.
    • Raising full year targets for revenue and non-GAAP EPS, based on strong execution and continued business momentum.

    SUNNYVALE, Calif., May 22, 2024 /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today reported results for its second quarter of fiscal year 2024. Revenue for the second quarter of fiscal year 2024 was $1.455 billion, compared to $1.263 billion for the second quarter of fiscal year 2023.  

    Synopsys headquarters in Sunnyvale, Calif. (PRNewsfoto/Synopsys, Inc.)

    "We continued our strong operational execution and business momentum in Q2. Customers continue investing in Synopsys solutions to maximize their R&D and power their future innovations for this era of pervasive intelligence," said Sassine Ghazi, president and CEO of Synopsys. "We expect our planned acquisition of Ansys, which was approved today by Ansys shareholders, to further our mission of empowering technology innovators everywhere with essential silicon to systems design solutions."

    "Synopsys' strong Q2 results were driven by our team's relentless focus on execution, our leading technology that is mission-critical to customers, and our resilient business model," said Shelagh Glaser, Synopsys CFO. "We remain confident in our business, and as a result, we are again raising our full-year targets for revenue and non-GAAP EPS."

    ________________________

    1 Synopsys' Software Integrity business has been presented as a discontinued operation in the consolidated financial statements for all periods presented herein and all financial results and targets are presented herein on a continuing operations basis unless otherwise noted.

    Continuing Operations

    On May 5, 2024, Synopsys entered into an agreement to sell its Software Integrity business. Unless otherwise noted, Synopsys' Software Integrity business has been presented as a discontinued operation in the consolidated financial statements for all periods presented herein and all financial results and targets are presented herein on a continuing operations basis.

    GAAP Results

    On a U.S. generally accepted accounting principles (GAAP) basis, net income for the second quarter of fiscal year 2024 was $299.1 million, or $1.92 per diluted share, compared to $275.6 million, or $1.78 per diluted share, for the second quarter of fiscal year 2023.

    Non-GAAP Results

    On a non-GAAP basis, net income for the second quarter of fiscal year 2024 was $466.9 million, or $3.00 per diluted share, compared to non-GAAP net income of $368.3 million, or $2.38 per diluted share, for the second quarter of fiscal year 2023.

    For a reconciliation of net income, earnings per diluted share and other measures on a GAAP and non-GAAP basis, see "GAAP to Non-GAAP Reconciliation" in the accompanying tables below. 

    Business Segments 

    Synopsys reports revenue and operating income in two segments: (1) Design Automation, which includes our advanced silicon design, verification products and services, system integration products and services, digital, custom and field programmable gate array (FPGA) IC design software, verification software and hardware products, manufacturing software products and other and (2) Design IP, which includes our Design IP products.

    Financial Targets 

    Synopsys also provided its consolidated financial targets for continuing operations for the third quarter and full fiscal year 2024. The fiscal year targets include the impact of an extra week in fiscal year 2024, which was included in the first quarter of fiscal year 2024. These financial targets assume no further changes to export control restrictions or the current U.S. government "Entity List" restrictions. These targets constitute forward-looking statements and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see "Forward-Looking Statements" below. 

    Third Quarter and Full Fiscal Year 2024 Financial Targets (1)(2)

    (in millions except per share amounts)















     Range for Three Months Ending



    Range for Fiscal Year Ending



    July 31, 2024



    October 31, 2024



    Low

    High



    Low

    High

    Revenue

    $              1,505

    $              1,535



    $              6,090

    $              6,150

    GAAP Expenses

    $              1,099

    $              1,119



    $              4,559

    $              4,614

    Non-GAAP Expenses

    $                 920

    $                 930



    $              3,770

    $              3,810

    Non-GAAP Interest and Other Income (Expense), net

    $                     4

    $                     6



    $                   32

    $                   36

    Non-GAAP Tax Rate

    15 %



    15 %

    Outstanding Shares (fully diluted)

    155

    157



    155

    157

    GAAP EPS

    $                2.22

    $                2.35



    $                9.14

    $                9.36

    Non-GAAP EPS

    $                3.25

    $                3.30



    $              12.90

    $              12.98

    Operating Cash Flow







    ~ $1,300

    Free Cash Flow(3)







    ~ $1,100

    Capital Expenditures







    ~ $200













    (1) Synopsys' third quarter of fiscal year 2024 and its fiscal year 2024 will end on August 3, 2024 and November 2, 2024, respectively. For

    presentation purposes, we refer to the closest calendar month end. The first quarter of fiscal year 2024 included one extra week.

    (2) Presented on a continuing operations basis.

    (3) Free cash flow is calculated as cash provided from operating activities less capital expenditures and capitalization of software

    development costs.

    For a reconciliation of Synopsys' third quarter and fiscal year 2024 targets, including expenses, earnings per diluted share and other measures on a GAAP and non-GAAP basis and a discussion of the financial targets that we are not able to reconcile without unreasonable efforts, see "GAAP to Non-GAAP Reconciliation" in the accompanying tables below. 

    Earnings Call Open to Investors

    Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys' corporate website at www.investor.synopsys.com. Synopsys uses its website as a tool to disclose important information about Synopsys and comply with its disclosure obligations under Regulation Fair Disclosure. A webcast replay will also be available on the corporate website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the third quarter of fiscal year 2024 in August 2024. 

    Effectiveness of Information

    The targets included in this press release, the statements made during the earnings conference call, the information contained in the financial supplement and the corporate overview presentation, each of which are available on Synopsys' corporate website at www.synopsys.com (collectively, the "Earnings Materials"), represent Synopsys' expectations and beliefs as of May 22, 2024. Although these Earnings Materials will remain available on Synopsys' website through the date of the earnings call for the third quarter of fiscal year 2024, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys undertakes no duty and does not intend to update any forward-looking statement, whether as a result of new information or future events, or otherwise update, the targets given in this press release unless required by law.

    Availability of Final Financial Statements

    Synopsys will include final financial statements for the second quarter of fiscal year 2024 in its quarterly report on Form 10-Q to be filed on or before June 13, 2024.

    About Synopsys

    Catalyzing the era of pervasive intelligence, Synopsys, Inc. (NASDAQ:SNPS) delivers trusted and comprehensive silicon to systems design solutions, from electronic design automation to silicon IP and system verification and validation. We partner closely with semiconductor and systems customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow. Learn more at www.synopsys.com.

    Reconciliation of Second Quarter Fiscal Year 2024 Results for Continuing Operations

    The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income, earnings per diluted share, and tax rate for the periods indicated below.

    GAAP to Non-GAAP Reconciliation of Second Quarter Fiscal Year 2024 Results(1)

    (unaudited and in thousands, except per share amounts)













    Three Months Ended

    Six Months Ended



    April 30,

    April 30,



    2024

    2023

    2024

    2023

    GAAP net income from continuing operations

    attributed to Synopsys

    $                299,111

    $        275,602

    $        736,561

    $        545,286

    Adjustments:









    Amortization of acquired intangible assets

    16,925

    11,387

    32,526

    23,640

    Stock-based compensation

    162,346

    130,114

    327,487

    252,352

    Acquisition/divestiture related items

    25,256

    2,641

    57,188

    4,975

    Restructuring charges

    —

    (5,578)

    —

    32,560

    Gain on sale of strategic investments

    —

    —

    (55,077)

    —

    Tax adjustments

    (36,694)

    (45,878)

    (106,261)

    (106,033)

    Non-GAAP net income from continuing operations

    attributed to Synopsys

    $               466,944

    $       368,288

    $       992,424

    $       752,780

































    Three Months Ended

    Six Months Ended



    April 30,

    April 30,



    2024

    2023

    2024

    2023

    GAAP net income from continuing operations per diluted share

    attributed to Synopsys

    $                      1.92

    $              1.78

    $              4.73

    $              3.52

    Adjustments:









    Amortization of acquired intangible assets

    0.11

    0.07

    0.21

    0.15

    Stock-based compensation

    1.04

    0.84

    2.10

    1.63

    Acquisition/divestiture related items

    0.16

    0.02

    0.37

    0.03

    Restructuring charges

    —

    (0.04)

    —

    0.21

    Gain on sale of strategic investments

    —

    —

    (0.35)

    —

    Tax adjustments

    (0.23)

    (0.29)

    (0.68)

    (0.68)

    Non-GAAP net income from continuing operations per diluted share

    attributed to Synopsys

    $                      3.00

    $              2.38

    $              6.38

    $              4.86





















    Shares used in computing net income per diluted share amounts:

    155,770

    154,730

    155,610

    155,044











    (1) Synopsys' second quarter of fiscal year 2024 and 2023 ended on May 4, 2024 and April 29, 2023, respectively. For

    presentation purposes, we refer to the closest calendar month end. The first quarter of fiscal year 2024 included one

    extra week.

     

    GAAP to Non-GAAP Tax Rate Reconciliation (1)(2)

    (unaudited)









    Three Months Ended

    Six Months Ended



    April 30, 2024

    April 30, 2024







    GAAP effective tax rate

    13.3 %

    8.6 %

    Income tax effect of above non-GAAP adjustments

    1.7 %

    6.4 %

    Non-GAAP effective tax rate

    15.0 %

    15.0 %







    (1) Synopsys' second quarter of fiscal year 2024 ended on May 4, 2024. For presentation purposes, we refer to the closest

    calendar month end. The first quarter of fiscal year 2024 included one extra week.

    (2) Presented on a continuing operations basis.

    Reconciliation of 2024 Targets for Continuing Operations

    The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.

    GAAP to Non-GAAP Reconciliation of Third Quarter Fiscal Year 2024 Targets (1)(2)

    (in thousands, except per share amounts)





















     Range for Three Months Ending





    July 31, 2024





    Low



    High

    Target GAAP expenses



    $        1,099,000



    $        1,119,000

    Adjustments:









          Amortization of acquired intangible assets



    (17,000)



    (20,000)

          Stock-based compensation



    (162,000)



    (169,000)

    Target non-GAAP expenses



    $           920,000



    $           930,000































    Range for Three Months Ending





    July 31, 2024





    Low



    High

    Target GAAP earnings per diluted share attributed to Synopsys



    $                 2.22



    $                 2.35

    Adjustments:









          Amortization of acquired intangible assets



    0.13



    0.11

          Stock-based compensation



    1.08



    1.04

          Acquisition/divestiture related items (3)



    0.10



    0.07

          Tax adjustments



    (0.28)



    (0.27)

    Target non-GAAP earnings per diluted share attributed to Synopsys



    $                 3.25



    $                 3.30











    Shares used in non-GAAP calculation (midpoint of target range)



    156,000



    156,000





















    GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2024 Targets (1)(2)

    (in thousands, except per share amounts)





















    Range for Fiscal Year Ending





    October 31, 2024





    Low



    High

    Target GAAP expenses



    $        4,559,099



    $        4,614,099

    Adjustments:









          Amortization of acquired intangible assets



    (67,000)



    (72,000)

          Stock-based compensation



    (672,000)



    (682,000)

          Acquisition/divestiture related items(3)



    (50,099)



    (50,099)

    Target non-GAAP expenses



    $        3,770,000



    $        3,810,000































    Range for Fiscal Year Ending





    October 31, 2024





    Low



    High

    Target GAAP earnings per diluted share attributed to Synopsys



    $                 9.14



    $                 9.36

    Adjustments:









          Amortization of acquired intangible assets



    0.46



    0.43

          Stock-based compensation



    4.37



    4.31

          Acquisition/divestiture related items(3)



    0.55



    0.49

          Gain on sale of strategic investments



    (0.35)



    (0.35)

          Tax adjustments



    (1.27)



    (1.26)

    Target non-GAAP earnings per diluted share attributed to Synopsys



    $               12.90



    $               12.98











    Shares used in non-GAAP calculation (midpoint of target range)



    156,000



    156,000











    (1) Synopsys' third quarter of fiscal year 2024 and its fiscal year 2024 will end on August 3, 2024 and November 2, 2024,

    respectively. For presentation purposes, we refer to the closest calendar month end. The first quarter of fiscal year 2024

    included one extra week.

    (2) Presented on a continuing operations basis.

    (3) Adjustments reflect actual expenses incurred by Synopsys as of May 4, 2024 as well as certain contractually obligated

    financing fees and related amortization expenses, and do not fully reflect all potential adjustments for future periods for the

    reasons set forth in "GAAP to Non-GAAP Reconciliation" below.

    Forward-Looking Statements

    This press release and the investor conference call contain forward-looking statements, including, but not limited to, statements regarding short-term and long-term financial targets, expectations and objectives, including, among others, the anticipated effects of our pending acquisition of ANSYS, Inc. (the Ansys Merger); strategies related to our products, technology and services; business and market outlook, opportunities, strategies and technological trends, such as artificial intelligence; the pending  Ansys Merger, including, among other things, its anticipated benefits; planned  dispositions and their expected impact, such as the previously announced divestiture of our Software Integrity business (the Software Integrity Divestiture); the potential impact of the uncertain macroeconomic and geopolitical environment on our financial results; the expected impact of U.S. and foreign government actions and regulatory changes, including export control restrictions on our financial results; customer demand and market expansion; our planned product releases and capabilities; industry growth rates; the expected realization of our contracted but unsatisfied or partially unsatisfied performance obligations (backlog); software trends; planned stock repurchases; our expected tax rate; and the impact and result of pending legal, administrative and tax proceedings. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: macroeconomic conditions and geopolitical uncertainty in the global economy; uncertainty in the growth of the semiconductor and electronics industries; the highly competitive industry we operate in; actions by the U.S. or foreign governments, such as the imposition of additional export restrictions or tariffs; consolidation among our customers and our dependence on a relatively small number of large customers; risks and compliance obligations relating to the global nature of our operations; failure to complete the Ansys Merger on the terms described in our filings with the SEC, if at all; failure to obtain required governmental approvals related to the Ansys Merger or the imposition of conditions to such governmental approvals that may have an adverse effect on us; failure to realize the benefits expected from the Ansys Merger; failure to complete the Software Integrity Divestiture, or the Software Integrity Divestiture disrupting our business or failing to achieve its intended benefits, and more. Additional information on potential risks, uncertainties and other factors that could affect Synopsys' results is included in filings we make with the SEC from time to time, including in the sections entitled "Risk Factors" in our latest Annual Report on Form 10-K and in our latest Quarterly Report on Form 10-Q. The financial information contained in this press release should be read in conjunction with the consolidated financial statements and notes thereto included in Synopsys' most recent reports on Forms 10-K and 10-Q, each as may be amended from time to time. Synopsys' financial results for its second quarter of fiscal year 2024 are not necessarily indicative of Synopsys' operating results for any future periods. The information provided herein is as of May 22, 2024. Synopsys undertakes no duty to, and does not intend to, update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

    SYNOPSYS, INC.

    Unaudited Condensed Consolidated Statements of Income (1)

    (in thousands, except per share amounts)



























    Three Months Ended



    Six Months Ended



    April 30,



    April 30,



    2024

    2023



    2024

    2023

    Revenue:











      Time-based products

    $            781,714

    $            717,845



    $          1,586,777

    $          1,408,135

      Upfront products

    396,389

    335,009



    838,755

    665,978

        Total products revenue

    1,178,103

    1,052,854



    2,425,532

    2,074,113

      Maintenance and service

    276,609

    209,890



    540,169

    422,128

          Total revenue

    1,454,712

    1,262,744



    2,965,701

    2,496,241

    Cost of revenue:











      Products

    198,719

    169,062



    374,217

    325,686

      Maintenance and service

    88,178

    68,687



    178,718

    136,855

      Amortization of acquired intangible assets

    13,500

    10,492



    26,655

    21,689

          Total cost of revenue

    300,397

    248,241



    579,590

    484,230

    Gross margin

    1,154,315

    1,014,503



    2,386,111

    2,012,011

    Operating expenses:











      Research and development

    493,136

    460,463



    1,018,670

    899,650

      Sales and marketing

    209,783

    180,658



    428,626

    352,212

      General and administrative

    114,763

    84,685



    246,027

    174,656

      Amortization of acquired intangible assets

    4,561

    1,900



    8,090

    3,935

      Restructuring charges

    —

    (5,578)



    —

    32,560

          Total operating expenses

    822,243

    722,128



    1,701,413

    1,463,013

    Operating income

    332,072

    292,375



    684,698

    548,998

    Interest and other income (expense), net

    9,458

    4,212



    114,286

    27,147

    Income before income taxes

    341,530

    296,587



    798,984

    576,145

    Provision (benefit) for income taxes

    45,437

    23,947



    68,346

    36,730

    Net income from continuing operations

    296,093

    272,640



    730,638

    539,415

    Income (loss) from discontinued operations, net of income taxes

    (7,004)

    (2,692)



    4,658

    (840)

    Net income

    289,089

    269,948



    735,296

    538,575

    Less: Net income (loss) attributed to non-controlling interest and

    redeemable non-controlling interest

    (3,018)

    (2,962)



    (5,923)

    (5,871)

    Net income attributed to Synopsys

    $            292,107

    $            272,910



    $            741,219

    $            544,446













    Net income (loss) attributed to Synopsys











     Continuing operations

    $            299,111

    $            275,602



    $            736,561

    $            545,286

     Discontinued operations

    (7,004)

    (2,692)



    4,658

    (840)

     Net income

    $            292,107

    $            272,910



    $            741,219

    $            544,446













    Net income (loss) per share attributed to Synopsys - basic:











      Continuing operations

    $                  1.96

    $                  1.81



    $                  4.83

    $                  3.58

      Discontinued operations

    (0.05)

    (0.02)



    0.03

    (0.01)

      Basic net income per share

    $                  1.91

    $                  1.79



    $                  4.86

    $                  3.57













    Net income (loss) per share attributed to Synopsys - diluted:











      Continuing operations

    $                  1.92

    $                  1.78



    $                  4.73

    $                  3.52

      Discontinued operations

    (0.04)

    (0.02)



    0.03

    (0.01)

      Diluted net income per share

    $                  1.88

    $                  1.76



    $                  4.76

    $                  3.51













    Shares used in computing per share amounts:











      Basic

    152,971

    152,187



    152,629

    152,294

      Diluted

    155,770

    154,730



    155,610

    155,044













    (1) Synopsys' second quarter of fiscal year 2024 and 2023 ended on May 4, 2024 and April 29, 2023, respectively. For

    presentation purposes, we refer to the closest calendar month end. The first quarter of fiscal year 2024 included one

    extra week.

     

    SYNOPSYS, INC.



    Unaudited Condensed Consolidated Balance Sheets (1)



    (in thousands, except par value amounts)













    April 30, 2024

    October 31, 2023



    ASSETS:







    Current assets:







      Cash and cash equivalents

    $          1,502,920

    $          1,433,966



      Short-term investments

    156,780

    151,639



              Total cash, cash equivalents and short-term investments

    1,659,700

    1,585,605



      Accounts receivable, net

    834,918

    856,660



      Inventories

    377,875

    325,590



      Prepaid and other current assets

    760,269

    548,115



      Current assets held for sale

    1,020,358

    114,654



              Total current assets

    4,653,120

    3,430,624



    Property and equipment, net

    566,832

    549,837



    Operating lease right-of-use assets, net

    528,011

    559,923



    Goodwill

    3,427,424

    3,346,065



    Intangible assets, net

    276,877

    239,577



    Deferred income taxes

    1,004,660

    853,526



    Other long-term assets

    554,913

    444,820



    Long-term assets held for sale

    —

    908,759



               Total assets

    $        11,011,837

    $        10,333,131











    LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND

    STOCKHOLDERS' EQUITY:







    Current liabilities:







      Accounts payable and accrued liabilities

    $            635,916

    $          1,059,914



      Operating lease liabilities

    84,550

    79,832



      Deferred revenue

    1,457,282

    1,559,461



      Current liabilities held for sale

    330,602

    286,244



               Total current liabilities

    2,508,350

    2,985,451



    Long-term operating lease liabilities

    543,207

    579,686



    Long-term deferred revenue

    307,965

    150,827



    Long-term debt

    16,960

    18,078



    Other long-term liabilities

    446,514

    381,531



    Long-term liabilities held for sale

    —

    33,257



               Total liabilities

    3,822,996

    4,148,830



    Redeemable non-controlling interest

    31,043

    31,043



    Stockholders' equity:







      Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding

    —

    —



      Common stock, $0.01 par value: 400,000 shares authorized; 153,204 and

    152,053 shares outstanding, respectively

    1,532

    1,521



      Capital in excess of par value

    1,182,829

    1,276,152



      Retained earnings

    7,478,366

    6,741,699



      Treasury stock, at cost: 4,056 and 5,207 shares, respectively

    (1,321,554)

    (1,675,650)



      Accumulated other comprehensive income (loss)

    (188,013)

    (196,414)



               Total Synopsys stockholders' equity

    7,153,160

    6,147,308



    Non-controlling interest

    4,638

    5,950



               Total stockholders' equity

    7,157,798

    6,153,258



               Total liabilities, redeemable non-controlling interest and stockholders' equity

    $        11,011,837

    $        10,333,131











    (1) Synopsys' second quarter of fiscal year 2024 ended on May 4, 2024 and its fiscal year 2023 ended on October 28, 2023,

    respectively. For presentation purposes, we refer to the closest calendar month end. The first quarter of fiscal year 2024 included

    one extra week.







     

    SYNOPSYS, INC.

    Unaudited Condensed Consolidated Statements of Cash Flows (1)

    (in thousands)









    Six Months Ended April 30,



    2024

    2023

    CASH FLOWS FROM OPERATING ACTIVITIES:





    Net income

    $            735,296

    $            538,575

    Adjustments to reconcile net income to net cash provided by operating activities:





    Amortization and depreciation

    123,886

    116,922

    Reduction of operating lease right-of-use assets

    48,179

    48,073

    Amortization of capitalized costs to obtain revenue contracts

    37,912

    39,588

    Stock-based compensation

    358,487

    277,485

    Allowance for credit losses

    9,987

    6,134

    Gain on sale of strategic investments

    (55,077)

    —

    Amortization of bridge financing costs

    7,085

    —

    Deferred income taxes

    (170,854)

    (125,090)

    Other non-cash

    (2,607)

    4,972

    Net changes in operating assets and liabilities, net of acquired assets and assumed liabilities:





    Accounts receivable

    20,889

    9,289

    Inventories

    (60,518)

    (48,648)

    Prepaid and other current assets

    (191,595)

    49,437

    Other long-term assets

    (104,551)

    (75,324)

    Accounts payable and accrued liabilities

    (142,086)

    (162,840)

    Operating lease liabilities

    (48,709)

    (31,634)

    Income taxes

    (229,536)

    94,587

    Deferred revenue

    52,612

    76,165

    Net cash provided by operating activities

    388,800

    817,691







    CASH FLOWS FROM INVESTING ACTIVITIES:





    Proceeds from sales and maturities of short-term investments

    63,159

    67,717

    Purchases of short-term investments

    (65,861)

    (68,738)

    Proceeds from sales of strategic investments

    55,696

    7,248

    Purchases of strategic investments

    (860)

    —

    Purchases of property and equipment

    (78,763)

    (91,368)

    Acquisitions, net of cash acquired

    (139,557)

    (41,324)

    Capitalization of software development costs

    —

    (1,247)

    Net cash used in investing activities

    (166,186)

    (127,712)







    CASH FLOWS FROM FINANCING ACTIVITIES:





    Repayment of debt

    (1,303)

    (1,294)

    Payment of bridge financing and term loan costs

    (54,715)

    —

    Issuances of common stock

    115,111

    132,808

    Payments for taxes related to net share settlement of equity awards

    (212,577)

    (116,838)

    Purchase of equity forward contract

    —

    (45,000)

    Purchases of treasury stock

    —

    (560,724)

    Other

    (1,096)

    (122)

    Net cash used in financing activities

    (154,580)

    (591,170)

    Effect of exchange rate changes on cash, cash equivalents and restricted cash

    2,423

    27,708

    Net change in cash, cash equivalents and restricted cash

    70,457

    126,517

    Cash, cash equivalents and restricted cash, beginning of year, including cash from discontinued operations

    1,441,187

    1,419,864

    Cash, cash equivalents and restricted cash, end of period, including cash from discontinued operations

    1,511,644

    1,546,381

    Less: Cash, cash equivalents and restricted cash from discontinued operations

    6,445

    4,140

    Cash, cash equivalents and restricted cash from continuing operations

    $          1,505,199

    $          1,542,241













    (1) Synopsys' second quarter of fiscal year 2024 and 2023 ended on May 4, 2024 and April 29, 2023, respectively. For

    presentation purposes, we refer to the closest calendar month end. The first quarter of fiscal year 2024 included

    one extra week.

    Synopsys provides segment information, namely revenue, adjusted segment operating income and adjusted segment operating margin, in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 280, Segment Reporting. Synopsys' chief operating decision maker ("CODM") is our Chief Executive Officer. In evaluating our business segments, the CODM considers the income and expenses that the CODM believes are directly related to those segments. The CODM does not allocate certain operating expenses managed at a consolidated level to our business segments and, as a result, the reported operating income and operating margin do not include these unallocated expenses as shown in the table below. These unallocated expenses are presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income from continuing operations:

    SYNOPSYS, INC.

    Business Segment Reporting (1)(2)(5)

    (in millions)













    Three Months Ended

    April 30, 2024

    Three Months Ended

    April 30, 2023

    Six Months Ended

    April 30, 2024

    Six Months Ended

    April 30, 2023



    Revenue by segment









    - Design Automation

    $                        1,054.9

    $                           927.5

    $                        2,040.3

    $                        1,817.4

    % of Total

    72.5 %

    73.5 %

    68.8 %

    72.8 %

    - Design IP

    $                           399.8

    $                           335.2

    $                           925.4

    $                           678.8

    % of Total

    27.5 %

    26.5 %

    31.2 %

    27.2 %











    Adjusted operating income by segment









    - Design Automation

    $                           418.2

    $                           353.4

    $                           777.7

    $                           692.8

    - Design IP

    $                           124.8

    $                             81.5

    $                           370.5

    $                           194.9











    Adjusted operating margin by segment









    - Design Automation

    39.6 %

    38.1 %

    38.1 %

    38.1 %

    - Design IP

    31.2 %

    24.3 %

    40.0 %

    28.7 %

     

    Total Adjusted Segment Operating Income Reconciliation (1)(2)(5)

    (in millions)













    Three Months Ended

    April 30, 2024

    Three Months Ended

    April 30, 2023

    Six Months Ended

    April 30, 2024

    Six Months Ended

    April 30, 2023



    GAAP total operating income – as reported

    $                           332.1

    $                           292.4

    $                           684.7

    $                           549.0

    Other expenses managed at consolidated level









    -Amortization of acquired intangible assets (3)

    18.1

    12.4

    34.7

    25.6

    -Stock-based compensation (3)

    162.7

    130.4

    328.2

    253.0

    -Non-qualified deferred compensation plan

    11.1

    2.8

    50.5

    22.6

    -Acquisition/divestiture related items (4)

    19.2

    2.6

    50.1

    5.0

    -Restructuring charges

    —

    (5.6)

    —

    32.6

    Total adjusted segment operating income

    $                           543.0

    $                           435.0

    $                        1,148.2

    $                           887.7











    (1) Synopsys manages the business on a long-term, annual basis, and considers quarterly fluctuations of revenue and profitability as normal elements of our

    business. Amounts may not foot due to rounding.

    (2) Synopsys' second quarter of fiscal year 2024 and 2023 ended on May 4, 2024 and April 29, 2023, respectively. For presentation purposes, we refer to the

    closest calendar month end. The first quarter of fiscal year 2024 included one extra week.

    (3) The adjustment includes non-GAAP expenses attributable to non-controlling interest and redeemable non-controlling interest.

    (4) The adjustment excludes the amortization of bridge financing costs entered into in connection with the pending acquisition of Ansys, that was recorded in

    interest and other income (expense), net in our unaudited condensed consolidated statements of income.

    (5)  Presented on a continuing operations basis.

    GAAP to Non-GAAP Reconciliation

    Synopsys continues to provide all information required in accordance with GAAP but acknowledges evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys' operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal budgeting and resource allocation purposes. This press release includes non-GAAP earnings per diluted share, non-GAAP net income and non-GAAP tax rate for the periods presented. It also includes future estimated ranges for non-GAAP expenses, non-GAAP interest and other income (expense), non-GAAP tax rate, non-GAAP earnings per diluted share and free cash flow. These non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

    When possible, Synopsys provides a reconciliation of non-GAAP financial measures to their most closely applicable GAAP financial measures. Synopsys is unable to provide a full reconciliation of certain third quarter and full fiscal year 2024 non-GAAP financial targets to the corresponding GAAP financial measures on a forward-looking basis because Synopsys believes that it would not be possible for it to have the required information necessary to quantitatively reconcile such measures with sufficient precision without unreasonable efforts due to, among other things, the potential variability and limited predictability of the excluded adjustment items necessary for a full reconciliation such as certain acquisition/divestiture related items, restructuring charges, tax deduction variability, changes in the fair value of non-qualified deferred compensation plan, and gains (losses) on the sale of strategic investments. For the same reasons, Synopsys is unable to address the probable significance of the unavailable information. 

    Synopsys' management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, as superior to, or as a substitute for, financial information prepared in accordance with GAAP. These non-GAAP financial measures are meant to supplement, and be viewed in conjunction with, the corresponding GAAP financial measures. Synopsys' management believes presentation of non-GAAP financial measures, when shown in conjunction with the corresponding GAAP financial measures, provides useful information to investors allowing them to view financial and business trends relating to our financial condition and results of operations through the eyes of management. Synopsys' management evaluates and makes decisions about our business operations using both GAAP financial measures and non-GAAP financial measures to help facilitate internal comparisons to Synopsys' historical operating results and forecasted targets, planning and forecasting in subsequent periods and comparisons to competitors' operating results.

    The following are descriptions of the adjustments made to reconcile non-GAAP financial measures (other than free cash flow) to the most directly comparable GAAP financial measures:

    (i) Amortization of acquired intangible assets. We incur expenses from amortization of acquired intangible assets, which include, among other things, core/developed technology, customer relationships, contract rights, trademarks and trade names, and other intangibles related to acquisitions. We amortize the intangible assets over their estimated useful lives. We do not enter into acquisitions on a predictable cycle. The amount of an acquisition's purchase price allocated to intangible assets and their estimated useful lives can vary significantly and are unique to each acquisition. We believe that the presentation of non-GAAP financial measures that adjust for the amortization of intangible assets provides investors and others with a consistent basis for comparison across accounting periods. We also exclude this item because such expenses are non-cash in nature and we believe the non-GAAP financial measures excluding this item provide meaningful supplemental information regarding our core operational performance and liquidity, and ability to invest in research and development and fund future acquisitions and capital expenditures.

    (ii) Stock-based compensation. Stock-based compensation expenses consist primarily of expenses related to restricted stock units, stock options, employee stock purchase rights and other stock awards, including such expenses associated with acquisitions. We exclude stock-based compensation expense from our non-GAAP financial measures primarily because it is not an expense that typically requires or will require cash settlement by us. Further, the expense for the fair value of the stock-based instruments we utilize may bear little resemblance to the actual value realized upon the vesting or future exercise of the related stock-based awards and, therefore, is not used by management to assess the core profitability of our business operations.

    (iii) Acquisition/divestiture related items. In connection with certain of our business combinations and/or divestitures, we incur significant expenses that we would not have otherwise incurred as part of our business operations. These expenses include, among other things, compensation expenses, professional fees and other direct expenses, concurrent restructuring activities and divestiture activities, including employee severance and other exit costs, bridge financing costs, costs related to integration activities, changes to the fair value of contingent consideration related to the acquired company, and amortization of the fair value difference of below-market value assets arising from arrangements entered into or acquired in conjunction with an acquisition. We also recognize the gains and losses from the mark-up of equity or cost method investments to fair value upon obtaining control through acquisition. We exclude these items because they are related to acquisitions and have no direct correlation to the core operation of our business. Further, because we do not acquire businesses on a predictable cycle and the terms of each transaction can vary significantly and are unique to each transaction, we believe it is useful to exclude such expenses when looking for a consistent basis for comparison across accounting periods.

    (iv) Restructuring charges. We initiate restructuring activities to align our costs to our operating plans and business strategies based on then-current economic conditions, and such activities have a specific and defined term. Restructuring costs generally include severance and other termination benefits related to voluntary retirement programs, involuntary headcount reductions and facilities closures. Such restructuring costs include elimination of operational redundancy, permanent reductions in workforce and facilities closures and, therefore, are not considered by us to be a part of the core operation of our business and are not used by management when assessing the core profitability and performance of our business operations.

    (v) Gains (losses) on the sale of strategic investments. We exclude gains and losses on the sale of equity investments in privately held companies because we do not believe they are reflective of our core business and operating results.

    (vi) Deferred compensation. We exclude changes in the fair value of our non-qualified deferred compensation plan because we do not use these to assess the core profitability of our business operations.

    (vii) Income tax effect of non-GAAP pre-tax adjustments. Excluding the income tax effect of non-GAAP pre-tax adjustments from the provision for income taxes assists investors in understanding the tax provision associated with those adjustments and the effect on net income. We utilize an annual non-GAAP tax rate in calculating non-GAAP financial measures to provide better consistency across interim reporting periods by eliminating the effects of certain non-recurring and other period-specific items, which can vary in size and frequency and do not necessarily reflect our normal operations, and to more closely align our tax rate with our expected geographic earnings mix. This annual non-GAAP tax rate is based on an evaluation of our historical and projected mix of U.S. and international profit before tax, taking into account the impact of non-GAAP adjustments, U.S. tax law changes, as well as other factors such as our current tax structure, existing tax positions and expected recurring tax incentives. Based on these considerations, we have elected to adopt a non-GAAP tax rate of 15% for fiscal year 2024.

    INVESTOR CONTACT:

    Trey Campbell

    Synopsys, Inc.

    650-584-4289

    [email protected]

    EDITORIAL CONTACT:

    Cara Walker

    Synopsys, Inc.

    650-584-5000

    [email protected]

    Synopsys (PRNewsfoto/Synopsys)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/synopsys-posts-financial-results-for-second-quarter-fiscal-year-2024-302153264.html

    SOURCE Synopsys, Inc.

    Get the next $SNPS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNPS

    DatePrice TargetRatingAnalyst
    1/13/2025$600.00Buy
    Redburn Atlantic
    11/22/2024$570.00Equal Weight
    Wells Fargo
    11/12/2024$675.00Buy
    Loop Capital
    10/22/2024$650.00Outperform
    Mizuho
    10/15/2024$660.00Buy
    Berenberg
    4/4/2024$665.00Overweight
    Piper Sandler
    11/30/2023$500.00 → $660.00Buy
    Needham
    11/10/2023$600.00Overweight
    Morgan Stanley
    More analyst ratings

    $SNPS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Redburn Atlantic initiated coverage on Synopsys with a new price target

      Redburn Atlantic initiated coverage of Synopsys with a rating of Buy and set a new price target of $600.00

      1/13/25 8:42:39 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Wells Fargo initiated coverage on Synopsys with a new price target

      Wells Fargo initiated coverage of Synopsys with a rating of Equal Weight and set a new price target of $570.00

      11/22/24 8:02:35 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Loop Capital initiated coverage on Synopsys with a new price target

      Loop Capital initiated coverage of Synopsys with a rating of Buy and set a new price target of $675.00

      11/12/24 7:51:10 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Synopsys Announces Earnings Release Date For Second Quarter Fiscal Year 2025

      SUNNYVALE, Calif., May 7, 2025  /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced it will report results for the second quarter fiscal year 2025 on Wednesday, May 28, 2025, after market close. The company will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to review its financial results and business outlook. Financial and other statistical information to be discussed on this conference call will be available on the corporate website at www.investor.synopsys.com immediately before the call. A live webcast will also be available on this sit

      5/7/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys and Intel Foundry Propel Angstrom-Scale Chip Designs on Intel 18A and Intel 18A-P Technologies

      Synopsys Production-Ready EDA Flows and Broadest IP Portfolio Deliver Leading PPA for Intel Foundry's Advanced Processes and Packaging Technologies Highlights Production-ready Synopsys digital and analog EDA flows for Intel 18A and Intel 18A-P technologies pave the way for broad adoption and accelerate development of high-performance designs; engaged in early design technology co-optimization for Intel 14A-EOptimized EDA reference flow with a unified exploration-to-signoff platform accelerates 2.5D/3D multi-die designs for Intel's EMIB-T advanced packaging technologyBroadest portfolio of high-performance and low-power IP for Intel 18A and expanded Synopsys IP support for Intel 18A-P offers

      4/29/25 12:00:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys and TSMC Usher In Angstrom-Scale Designs with Certified EDA Flows on Advanced TSMC A16 and N2P Processes

      AI-Driven Digital and Analog Flows, Multi-Die Innovations, and Broad IP Portfolio Deliver Unmatched Performance, Power and Area Advantages Highlights Digital and analog design flows on TSMC A16™ and N2P deliver optimized performance and rapid analog design migration, enabled by Synopsys.aiEarly collaboration on TSMC A14 process underway for Synopsys EDA flows developmentCollaboration on 3Dblox and TSMC's CoWoS® technologies for 5.5x reticle size packages, speeds integration of 3D stacked dies in next-generation AI chipsBroad portfolio of Synopsys Foundation and Interface IP provides the lowest power on TSMC's N2/N2P processesIndustry's most complete IP solutions for leading-edge standards, i

      4/23/25 4:00:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Casper Marc N bought $439,087 worth of shares (750 units at $585.45), increasing direct ownership by 76% to 1,736 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      3/27/24 11:12:13 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Leadership Updates

    Live Leadership Updates

    See more
    • Clearlake and Francisco Partners Complete Acquisition of Black Duck Software, Formerly Known as Synopsys Software Integrity Group

      The standalone application security company continues its mission to help organizations build trust in their software to support innovation and business transformation SANTA MONICA, Calif. and SAN FRANCISCO, Oct. 1, 2024 /PRNewswire/ -- Clearlake Capital Group ("Clearlake") and Francisco Partners announced today that they have completed their acquisition of the Synopsys Software Integrity Group, establishing the newly independent application security company as Black Duck Software, Inc. ("Black Duck"). The transaction with Synopsys, Inc. (NASDAQ:SNPS), which was first announced on May 6, 2024, is valued at up to $2.1 billion, including up to $475 million in cash payable upon Clearlake and Fr

      10/1/24 9:06:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Clearlake and Francisco Partners Complete Acquisition of Black Duck Software, Formerly Known as Synopsys Software Integrity Group

      The standalone application security company continues its mission to help organizations build trust in their software to support innovation and business transformation Clearlake Capital Group ("Clearlake") and Francisco Partners announced today that they have completed their acquisition of the Synopsys Software Integrity Group, establishing the newly independent application security company as Black Duck Software, Inc. ("Black Duck"). The transaction with Synopsys, Inc. (NASDAQ:SNPS), which was first announced on May 6, 2024, is valued at up to $2.1 billion, including up to $475 million in cash payable upon Clearlake and Francisco Partners achieving a specified rate of return in connection

      10/1/24 8:30:00 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • SiMa.ai Secures Funds and Readies New Generative Edge AI Platform

      Oversubscribed $70M round led by Maverick Capital increases SiMa.ai's total amount raised to $270M; funding will speed release of next generation AI/ML chip to power multimodal generative AI at the edge SiMa.ai, the software-centric, embedded edge machine learning system-on-chip company, today announced it has raised an additional $70M of funding led by Maverick Capital, with participation from Point72 and Jericho, as well as existing investors Amplify Partners, Dell Technologies Capital, Lip-Bu Tan and others. SiMa.ai will utilize the $270M raised to date to continue meeting customer demand for edge AI/ML with its first-generation Machine Learning System-on-Chip (MLSoC) while acceleratin

      4/4/24 9:00:00 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    SEC Filings

    See more
    • Synopsys Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

      8-K - SYNOPSYS INC (0000883241) (Filer)

      3/17/25 4:30:50 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - SYNOPSYS INC (0000883241) (Filer)

      3/5/25 5:18:49 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 424B5 filed by Synopsys Inc.

      424B5 - SYNOPSYS INC (0000883241) (Filer)

      3/5/25 5:17:50 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Synopsys Inc. (Amendment)

      SC 13G/A - SYNOPSYS INC (0000883241) (Subject)

      2/14/23 12:37:55 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Synopsys Inc. (Amendment)

      SC 13G/A - SYNOPSYS INC (0000883241) (Subject)

      2/9/23 11:32:50 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Synopsys Inc. (Amendment)

      SC 13G/A - SYNOPSYS INC (0000883241) (Subject)

      2/14/22 2:34:19 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Financials

    Live finance-specific insights

    See more
    • Synopsys Announces Earnings Release Date For Second Quarter Fiscal Year 2025

      SUNNYVALE, Calif., May 7, 2025  /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced it will report results for the second quarter fiscal year 2025 on Wednesday, May 28, 2025, after market close. The company will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to review its financial results and business outlook. Financial and other statistical information to be discussed on this conference call will be available on the corporate website at www.investor.synopsys.com immediately before the call. A live webcast will also be available on this sit

      5/7/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys Posts Financial Results for First Quarter Fiscal Year 2025

      Results Summary Quarterly revenue of $1.455 billion, exceeding midpoint of guidance.Quarterly GAAP earnings per diluted share of $1.89; non-GAAP earnings per diluted share of $3.03, exceeding guidance.Reaffirming full-year 2025 guidance.SUNNYVALE, Calif., Feb. 26, 2025 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today reported results for its first quarter of fiscal year 2025. Revenue for the first quarter of fiscal year 2025 was $1.455 billion, compared to $1.511 billion for the first quarter of fiscal year 2024. "In Q1, Synopsys' relentless focus on execution and innovatio

      2/26/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys Announces Earnings Release Date For First Quarter Fiscal Year 2025

      SUNNYVALE, Calif., Jan. 27, 2025 /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced it will report results for the first quarter fiscal year 2025 on Wednesday, February 26, 2025, after the market close. The company will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to review its financial results and business outlook. Financial and other statistical information to be discussed on this conference call will be available on the corporate website at www.investor.synopsys.com immediately before the call. A live webcast will also be available on

      1/27/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Schwarz John was granted 491 shares, increasing direct ownership by 4% to 12,787 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      4/14/25 4:22:48 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Director Sargent Jeannine P was granted 491 shares, increasing direct ownership by 24% to 2,544 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      4/14/25 4:22:16 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Director Painter Robert G was granted 491 shares, increasing direct ownership by 34% to 1,941 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      4/14/25 4:21:38 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology